As Asian medical markets grow, so do biotech and medtech opportunities

 31-Oct-17, Forbes 

Asia will become the second highest medical technology market in the world by 2020, and it could account for a third of global sales by 2025. The opportunity is great, and with good reason. Until the last decade, many Asian countries were largely underserved by pharmaceutical companies and medtech providers.

Image: Starnews / AFP /Getty Images

Carl Firth, CEO of Singapore-based ASLAN Pharmaceuticals said "there has been a sea change" in the pharmaceutical industry and that major pharmaceutical companies are now more interested in developing treatments for Asia-prevalent diseases. 

Fredrik Nyberg, CEO of APACMed said, "Asia-Pacific used to be very much about Japan, then China, but not much else. Then about five years ago, Asia-Pacific started to represent 15-20% of global revenue... all of a sudden, you hear discussions in boardrooms in the US and Europe mention Indonesia and Vietnam and India."

 Read the full article  

 Insights